Literature DB >> 15056480

Buprenorphine in the treatment of opioid dependence.

Eugen Davids1, Markus Gastpar.   

Abstract

Buprenorphine has become of increasing interest to be an alternative to methadone in the treatment of heroin addicts. The aim of the paper is to review, from a clinical perspective, the current status of what is known about the pharmacology of buprenorphine, with a particular emphasis on the issues of maintenance therapy in heroin addiction. A systematic review of published follow-up data, from observational and experimental studies was done. Electronic databases Medline and PSYNDEXplus were searched from their earliest entries. Buprenorphine appears to be a well-tolerated drug, with a benign overall side effect. Buprenorphine is an additional treatment option for heroin dependent patients, especially for those who do not wish to start or continue with methadone or for those who do not seem to benefit from adequate dosages of methadone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056480     DOI: 10.1016/S0924-977X(03)00146-9

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  16 in total

1.  Is methadone too dangerous for opiate addiction?

Authors:  Jason Luty; Colin O'Gara; Mohammed Sessay
Journal:  BMJ       Date:  2005-12-10

2.  [Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure].

Authors:  J Jage; F Heid
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

Review 3.  [Maintenance treatment of opiate addicts].

Authors:  N Scherbaum
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

Review 4.  [Update palliative pain therapy].

Authors:  R Rolke; S Rolke; S Hiddemann; M Mücke; H Cuhls; L Radbruch; F Elsner; V Peuckmann-Post
Journal:  Internist (Berl)       Date:  2016-10       Impact factor: 0.743

Review 5.  Probuphine® (buprenorphine implant): a promising candidate in opioid dependence.

Authors:  Preeti Barnwal; Saibal Das; Somnath Mondal; Anand Ramasamy; Tanay Maiti; Arunava Saha
Journal:  Ther Adv Psychopharmacol       Date:  2016-12-19

6.  [Pain management in palliative care. Current aspects of medicinal therapy].

Authors:  H Cuhls; L Radbruch; A Brunsch-Radbruch; G Schmidt-Wolf; R Rolke
Journal:  Internist (Berl)       Date:  2013-02       Impact factor: 0.743

Review 7.  Buprenorphine use in pregnant opioid users: a critical review.

Authors:  Michael Soyka
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

Review 8.  Dependence on Prescription Opioids.

Authors:  Johannes Just; Martin Mücke; Markus Bleckwenn
Journal:  Dtsch Arztebl Int       Date:  2016-04-01       Impact factor: 5.594

9.  A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.

Authors:  Antonio Ferragud; Clara Velázquez-Sánchez; Vicente Hernández-Rabaza; Amparo Nácher; Virginia Merino; Miguel Cardá; Juan Murga; Juan J Canales
Journal:  Psychopharmacology (Berl)       Date:  2009-09-16       Impact factor: 4.530

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.